Allison, Bax, Doudna and Chang receive NAS prizes

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
James Allison
Adriaan Bax,
Jennifer A. Doudna
Howard Y. Chang,

James Allison, of MD Anderson Cancer Center, will receive the Jessie Stevenson Kovalenko Medal from the National Academy of Sciences.

Altogether, 19 individuals with awards in recognition of their extraordinary scientific achievements in a wide range of fields spanning the physical, biological, and medical sciences. The winners will be honored in a ceremony April 29, during the National Academy of Sciences’ 155th annual meeting.

Allison’s research has had a vast impact on cancer therapy and the evolution of the entire field of cancer immunology. In 1983, Allison reported on the protein structure of T cell receptor, providing one of the earliest looks at the molecules involved in T cell function.

This led to the discovery of two molecules related to the activation of T cells, CD28 and CTLA-4, the second of which functions as an inhibitor that restricts T cell responses. In 1996 Allison showed that blocking CTLA-4 led to tumor rejection in mice. This opened up the field of “immune checkpoint therapy,” a paradigm shift in cancer treatment which targeted the immune system rather than tumors themselves.

After several years of clinical trials, CTLA-4 was approved as a standard treatment for patients with metastatic melanoma. It is currently being tested in several additional forms of tumors and has already benefitted the lives of tens of thousands of patients.

The Jessie Stevenson Kovalenko Medal is awarded every two years for outstanding research in the medical sciences. The award is presented with a medal, a $25,000 prize and $50,000 to support the recipient’s research.

Adriaan Bax, an NIH Distinguished Investigator, will receive the 2018 NAS Award for Scientific Reviewing.

Bax is responsible for transforming Nuclear Magnetic Resonance spectroscopy into a powerful and readily accessible tool for the study of the structure, function, and dynamics of biological macromolecules. His development of a constant stream of novel methods has led to important advances in our basic understanding of how biological systems work at the molecular level.

Bax has published more than 400 original research articles on NMR methods and applications. His book, “Two-Dimensional Nuclear Magnetic Resonance in Liquids,” was the springboard for the widespread evolution of this technology.

His conceptual innovations and pioneering experimental methodologies have been widely adopted by chemistry and structural biology laboratories, influencing research in both academic institutions and the worldwide pharmacological industry. Beyond development of the technology itself, Bax has applied NMR to a wide range of biomedical problems, with important discoveries on proteins related to HIV and Parkinson’s disease.

The 2018 NAS Award for Scientific Reviewing recognizes authors, whose reviews in structural biology have synthesized extensive and difficult material, rendering a significant service to science and influencing the course of scientific thought. The award is sponsored entirely by Annual Reviews and is presented with a $20,000 prize.

Jennifer A. Doudna, principal investigator at University of California, Berkeley, will receive the 2018 NAS Award in Chemical Sciences.

Following pioneering discoveries on how RNA can fold to function in complex ways, Doudna, along with Emmanuelle Charpentier, invented the technology for efficient site-specific genome engineering using the CRISPR/Cas9 nucleases for genome editing—a breakthrough technology which has had an immediate and wide impact on all areas of both basic and applied life sciences.

CRISPR genome editing allows precise changing of the DNA code in human cells, as well as in those of other multicellular organisms. It has the potential to create new defenses against human viruses or to correct mutated human genes and provides methods to reshape the biosphere for the benefit of the environment and human societies. CRISPR genome editing has already been adopted by tens of thousands of laboratories around the world, where it has enabled and stimulated diverse experiments that were never before simple to conduct or possible to conceive.

The NAS Award in Chemical Sciences is presented annually to honor innovative research in the chemical sciences that contributes to a better understanding of the natural sciences and to the benefit of humanity. The NAS Award in Chemical Sciences was established in 1978 and supported by Occidental Petroleum Corporation from 1978 to 1996. The Merck Company Foundation assumed sponsorship in 1999. The award is presented with a medal and a $15,000 prize.

Howard Y. Chang, Howard Y. Chang, Stanford University School of Medicine, will receive the 2018 NAS Award in Molecular Biology.

Chang is a physician-scientist who made major contributions to genome science in his discoveries about a new class of genes called long noncoding RNAs, which are pervasive in the human genome.

Long noncoding RNAs are important causes of cancer metastasis and other human diseases, as well as development and aging. His work showed that long noncoding RNAs can act as guides, scaffolds, or decoys between DNA and enzyme machines.

These discoveries themselves would not have been possible without Dr. Chang’s invention of new genomic technologies such as ATAC-seq, which maps open chromatic sites with enzymes that copy and paste DNA, and ChIRP-seq, which maps RNA occupancy sites on the genome. ATAC-seq in particular has revolutionized the field of epigenetics, improving the ability to map active DNA elements by 1 million-fold in sensitivity and 100-fold in speed. Dr. Chang’s genomic technologies have already been widely adopted by investigators in thousands of labs around the world and have revolutionized the study of many human diseases and model organisms.

The NAS Award in Molecular Biology is supported by Pfizer Inc. and recognizes a recent notable discovery in molecular biology by a young scientist (defined as no older than 45) who is a citizen of the United States. The award is presented with a medal and a $25,000 prize.

YOU MAY BE INTERESTED IN

U.S. Deputy Secretary for Health and Human Services, Andrea Palm, and Sweden's Minister for Health Care, Acko Ankarberg Johansson, signing the agreement. Credit: Joel Apelthun/Government Offices of SwedenThe United States and Sweden signed an agreement to step up collaborations in science and technology by focusing on cancer research.

Login